Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,190 across all filing types
Latest filing 2023-11-21 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Strides Pharma Science Limited's subsidiary has received USFDA approval for a pharmaceutical product. It contains no financial statements, no detailed financial analysis, no regulatory certifications, or voting results. The document is a corporate announcement about a product approval, which is typical for a press release. It is not an Annual Report, Earnings Release, or any other detailed financial or regulatory filing. The document length is 3222 characters, which is short and consistent with a press release. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories.
2023-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on October 30, 2023, discussing the company's financial results for the quarter and half year ended September 30, 2023. It includes management commentary on financial performance, business outlook, and Q&A with investors. The text explicitly mentions it is an "Earnings Call transcript" and contains substantive financial discussion and analysis. Therefore, it fits the category of a Call Transcript (CT).
2023-11-03 English
Copy of Newspaper Publication
Regulatory Filings
2023-10-31 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a letter addressed to stock exchanges regarding compliance under SEBI regulations about the issuance of duplicate share certificates to a shareholder. It includes details of the shareholder, old and new certificate numbers, and proof of dispatch. There is no financial data, report, or management discussion. The document is a regulatory compliance notification related to share certificate issuance, which does not fit into financial reports, earnings, or management information categories. It is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and compliance document under SEBI listing obligations.
2023-10-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an earnings call for the quarter and half-year ended September 30, 2023. It references un-audited financial results and provides a link to the recording of the earnings call. The document does not contain actual financial data or detailed financial statements but is an announcement related to the earnings call. Therefore, it fits the category of a Call Transcript (CT) announcement or related material. Given the content is about the earnings call recording, the best classification is Call Transcript (CT). The document length is short and it is not the transcript itself but an announcement of the recording, but since the category CT includes full text transcripts and related call materials, this is the closest fit rather than a Regulatory Filing or Report Publication Announcement. Confidence is high due to clear mention of earnings call and financial period.
2023-10-30 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding changes in senior management personnel, specifically the resignation of the Chief Operating Officer and the appointment of a new COO. It includes resignation letters and detailed profiles related to these management changes. There are no financial statements, earnings data, or regulatory filings about financial performance. The document is clearly about management changes and complies with SEBI regulations for disclosure. Therefore, it fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive management change disclosure.
2023-10-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.